Leaked news from the future.
Tap to receive
Retatrutide will not get FDA approval before December 31, 2026. Eli Lilly will defer a final approval push until it files a Biologics License Application, which the company plans to submit in the first quarter of 2027, and retatrutide was not FDA approved as of October 2026. An appeals court heard…